BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — July 20, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

3 total filings analysed

Executive Summary

This digest covers three high-value federal contracts totaling $5.2 billion, all civilian (0% defense), with a dominant $4.8 billion award to Leidos Biomedical Research Inc. from HHS. The highest-conviction signal is the Leidos award, which is classified as a defense contract from a civilian agency, suggesting potential misclassification or dual-use biomedical research with defense applications.

A key risk is the $0 outlayed amount on the $192 million Cardinal Intellectual Property contract, indicating possible delays or non-activation, while the $190 million OptumServe VA contract is nearly fully executed, signaling strong cash flow realization but limited future visibility.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from July 12, 2026.

Investment Signals (3)

  • Leidos Biomedical Research Inc. Secures $4.81B HHS Award — Largest Civilian Contract in Period (HIGH)

    Leidos Biomedical Research Inc. received a $4.81B contract from HHS, representing 93% of total obligation value. Despite being classified as a defense contract from a civilian agency, this signals deep government trust and recurring revenue potential for Leidos in biomedical research.

  • OptumServe Health Services (UnitedHealth Group) Executes $190M VA Contract at 92.4% Outlay Rate (HIGH)

    OptumServe's $190M firm-fixed-price contract with VA for medical disability exams shows near-complete execution ($175.7M outlayed), demonstrating strong cost management and cash flow realization for UnitedHealth Group's government services arm.

  • Cardinal Intellectual Property Inc. $192M USPTO Contract Shows $0 Outlayed — Activation Risk (MEDIUM)

    Cardinal Intellectual Property Inc.'s $192M firm-fixed-price contract with USPTO has $0 outlayed despite a 2012 award date, suggesting the contract may be inactive, delayed, or revenue not yet recognized, posing execution risk.

Risk Flags (3)

  • Execution [HIGH RISK]

    Cardinal Intellectual Property Inc.'s $192M USPTO contract has $0 outlayed, indicating potential non-activation or revenue recognition delays, which could impact cash flow projections.

  • Concentration [MEDIUM RISK]

    Leidos Biomedical Research Inc. accounts for 93% of total obligation value ($4.81B of $5.2B), creating single-contract concentration risk for Leidos if HHS priorities shift or funding is disrupted.

  • Competition [MEDIUM RISK]

    OptumServe's $190M VA contract is fully executed with no option periods, exposing UnitedHealth Group to recompetition risk for Region 2 disability exams.

Opportunities (2)

  • Leidos Biomedical Research Inc.'s $4.81B HHS award signals sustained government investment in biomedical research, creating growth opportunities for Leidos in civilian health contracts.

  • OptumServe's near-complete $190M VA contract execution positions UnitedHealth Group for follow-on awards in VA medical disability services, a recurring need tied to veteran benefits.

Sector Themes (2)

  • The $4.81B Leidos HHS award underscores massive civilian agency spending on biomedical research, with defense classification suggesting dual-use applications. This dwarfs other civilian contracts in the period.

  • OptumServe's $190M VA contract with 92.4% outlay rate confirms recurring demand for veteran medical disability exams, a stable civilian sector tied to entitlement programs.

Watch List (3)

  • 👁

    {"entity"=>"Cardinal Intellectual Property Inc.", "reason"=>"$192M USPTO contract with $0 outlayed suggests potential activation issues or revenue recognition delays.", "trigger"=>"Quarterly outlayed amount updates, contract modification announcements"}

  • 👁

    {"entity"=>"Leidos Holdings", "reason"=>"93% of digest value concentrated in one $4.81B HHS contract; any funding disruption could materially impact revenue.", "trigger"=>"HHS budget appropriations, NDAA biomedical research provisions"}

  • 👁

    {"entity"=>"UnitedHealth Group", "reason"=>"OptumServe's $190M VA contract is fully executed; recompetition risk for Region 2 disability exams is imminent.", "trigger"=>"New VA solicitations for Region 2 disability exams"}

Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 3 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →